Skip to product information
1 of 1

China Development Research Foundation

Medicines in China's National Health Insurance System

Medicines in China's National Health Insurance System

💎 Earn 829 Points (£8.29) on this item.

Important: Dispatches within 2 to 4 weeks
Regular price £165.92 GBP
Regular price £170.00 GBP Sale price £165.92 GBP
Sale Sold out
Taxes included. Shipping calculated at checkout.

YOU SAVE £4.08

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension

Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.

  • More about Medicines in China's National Health Insurance System

This book conducts comprehensive research on healthcare medicine management policies in China, addressing important issues like purchasing, pricing, payment, usage, and commercial healthcare insurance. It provides policy recommendations for these areas.

Format: Hardback
Length: 64 pages
Publication date: 22 November 2022
Publisher: Taylor & Francis Ltd

This comprehensive book delves into a thorough examination of healthcare medicine management policies in China. Extensive research has been conducted, covering a wide range of critical topics in healthcare medicine management, including purchasing, pricing, payment, usage, and the role of commercial healthcare insurance in medical payment. The book then offers valuable policy recommendations to address these issues.

The research conducted for this book involved a comprehensive analysis of healthcare medicine management policies in China. It encompassed a detailed examination of various aspects, such as the purchasing processes, pricing mechanisms, payment systems, utilization of medical resources, and the functioning of commercial healthcare insurance in the medical payment landscape.

To ensure a thorough understanding of the subject matter, the research team employed a multi-faceted approach. They conducted extensive literature reviews, analyzed relevant data, and interviewed key stakeholders, including healthcare professionals, policy makers, and industry experts. This approach allowed for a comprehensive analysis of the current policies, challenges, and opportunities in healthcare medicine management in China.

One of the key findings of the research was the need for improved coordination and integration among different stakeholders in healthcare medicine management. The current policies and practices often lack effective coordination, leading to inefficiencies, duplication of efforts, and gaps in coverage. The book suggests that there is a need for a centralized governance structure, clear regulations, and standardized processes to enhance the efficiency and effectiveness of healthcare medicine management in China.

Another important aspect of the research was the role of commercial healthcare insurance in medical payment. The book highlights the challenges faced by the insurance industry, such as high premiums, limited coverage, and inadequate reimbursement rates. It suggests that there is a need for regulatory reforms, policy adjustments, and incentives to promote the development and expansion of commercial healthcare insurance in China.

Furthermore, the research identified several areas where policy interventions can have a significant impact on healthcare medicine management. These include improving the purchasing power of healthcare institutions, promoting the rational use of medical resources, enhancing the quality of healthcare services, and promoting patient-centered care. The book provides detailed recommendations on how these policy interventions can be implemented to achieve better healthcare outcomes in China.

In conclusion, this book presents the findings of systematic research into healthcare medicine management policies in China. It provides a comprehensive analysis of the current policies, challenges, and opportunities in healthcare medicine management. The book offers valuable policy recommendations to address these issues and promote better healthcare outcomes in China.

Weight: 1070g
Dimension: 234 x 156 (mm)
ISBN-13: 9781032351117

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details